1Sheline YI,Freedland KE,Carney RM. How safe are serotonin reuptake inhibitons for depression in patients with coronary heart disease? AM J Med, 1997,102:54-59.
2Barefoot JC,Helms M J, Mark DM,et al. Depression and long term mortality risk in patients with Coronary artery disease. AM J Cardiol, 1996,78,613-617.
3Simon GE. Can depression be managed appropriately in primary care? J Clin Psychiatry, 1998,59(Suppl): 3-8.
4Pini S, Berardi D, Rucci P, et al. Identification of psychiatric distress by primary care physicians. Gen Hosp Psychiatry,1997, 19:411-418.
5Wilson GA, Furman BL. Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycemia in mice. Eur J Pharmacol, 1982,78 : 263-270.
6Goodnick PJ,Henry JH, Buki VMV. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry , 1995,56 : 128-136.
7Lustman PJ ,Harper GW ,Griffith LS,et al. Use of the diagnostic interview schedule in patients with diabetes mellitus. J Nerv Ment Dis, 1986,174:743-746.
8Blundell JE. Serotonin and appetite. Neuropharmacology, 1984,23:1537-1551.
9Kurita A,et al. Diabetes Care . 1996
10Vervoot G. et al. Journal of Hypertension . 1999
